These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 718128)

  • 1. [Effect of L dopa, dopamine and CB 154 on prolactin secretion from human pituitary adenomas in vitro (proceedings) (author's transl)].
    Peillon F; Cesselin F; Zygelman N; Brandi A; Mauborgne A
    Ann Endocrinol (Paris); 1978; 39(3):255-7. PubMed ID: 718128
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pituitary adenomas with hypersecretion of TSH and prolactin. Evidence that receptor sites for dopamin may be absent on TSH producing while present on prolactin producing cells.
    Werner S
    Horm Metab Res; 1979 Jul; 11(7):452-3. PubMed ID: 113330
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
    Tallo D; Malarkey WB
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological study of a prolactin-secreting pituitary adenoma after therapy with 2-bromo-alpha-erogocryptine (CB154) (author's transl)].
    Beauvillain JC; Tramu G; Mazzuca M; Christiaens JL; L'Hermite ML; Asfour M; Fossati P; Linquette M
    Ann Endocrinol (Paris); 1976; 37(2):117-8. PubMed ID: 1036873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix.
    Bethea CL; Ramsdell JS; Jaffe RB; Wilson CB; Weiner RI
    J Clin Endocrinol Metab; 1982 May; 54(5):893-902. PubMed ID: 6801076
    [No Abstract]   [Full Text] [Related]  

  • 7. [Longitudinal study of 18 cases of prolactin adenoma. Therapeutic results (author's transl)].
    de Gennes JL; Turpin G; Heshmati HM; Cesselin E; Lagoguey M
    Nouv Presse Med; 1978 May; 7(20):1713-7. PubMed ID: 673715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-tumorous effect of bromocriptine in prolactin-secreting adenomas. A case-report (author's transl)].
    Bigorgne JC; Rohmer V; Mercier P; Galland F
    Sem Hop; 1982 Mar; 58(11):679-82. PubMed ID: 6278614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumoral development of prolactin-secreting pituitary adenomas during pregnancy. Therapeutic approaches (author's transl)].
    Rohmer V; Strauch G; Luton JP; Bricaire H
    Nouv Presse Med; 1981 Dec; 10(46):3783-6. PubMed ID: 6172776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary function in 20 cases of prolactinoma in females.
    Eşanu C; Klepsch I; Calciu G; Bucur D; Popescu LG
    Endocrinologie; 1983; 21(2):131-9. PubMed ID: 6408728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
    Genazzani AR; De Leo V; Murru S; Cocchi D; Camanni F; Müller EE
    J Clin Endocrinol Metab; 1982 Feb; 54(2):429-35. PubMed ID: 7054227
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proceedings: Prolactin adenomas; a morphological study. Correlations between clinical and anatomical data in 91 cases (author's transl)].
    Peillon F; Racadot J; Olivier L; Racadot O; Vila-Porcile E
    Ann Endocrinol (Paris); 1975; 36(5):277-8. PubMed ID: 1217865
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of Forbes-Albright syndrome treated with CB-154: has the tumor really disappeared? (author's transl)].
    Kobayashi S; Shimura T; Nakazawa S
    No Shinkei Geka; 1980 May; 8(5):463-7. PubMed ID: 7383261
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.
    Israel JM; Jaquet P; Vincent JD
    Endocrinology; 1985 Oct; 117(4):1448-55. PubMed ID: 4029087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide.
    Spada A; Nicosia S; Cortelazzi L; Pezzo G; Bassetti M; Sartorio A; Giannattasio G
    J Clin Endocrinol Metab; 1983 Jan; 56(1):1-10. PubMed ID: 6292253
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
    Muechler EK; Huang KE; McDonald JV; Tang L
    Am J Obstet Gynecol; 1987 Aug; 157(2):453-5. PubMed ID: 3113252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen enhances the sensitivity of dispersed prolactin-secreting pituitary tumor cells to dopamine and bromocriptine.
    de Quijada M; Timmermans HA; Lamberts SW; MacLeod RM
    Endocrinology; 1980 Mar; 106(3):702-6. PubMed ID: 6766385
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Follow up of 30 cases of prolactin -- or somatotropin -- secreting adenomas after trans-spenoidal surgery (author's transl)(proceedings)].
    Jaquet P; Grisoli F; Guibout M; Lissitzky JC
    Ann Endocrinol (Paris); 1976; 37(4):283-4. PubMed ID: 828840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.